Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (201-210 of 403) with videos related to

Pageof 41
Sort By:
Haematologica|November 27, 2014
Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoringUta Oelschlaegel, Theresia M Westers, Brigitte Mohr, et al.
Oncotarget|September 15, 2017
Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpressionTheresa Link, Friederike Kuithan, Armin Ehninger, et al.
Haematologica|June 7, 2007
Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia IntergroupMarkus Schaich, Richard F Schlenk, Haifa K Al-Ali, et al.
Analytical Biochemistry|January 26, 2012
Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapsesSlava Stamova, Anja Feldmann, Marc Cartellieri, et al.
Frontiers in Genetics|January 24, 2022
Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal CancerSebastian Stasik, Marika Mende, Caroline Schuster, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2003
Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588Philipp le Coutre, Karl-Anton Kreuzer, Stefan Pursche, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 20, 2017
Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing RegimensAnna Hecht, Seraphina Doll, Heidi Altmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemiaOlle Ringdén, Myriam Labopin, Gerhard Ehninger, et al.
Blood|April 17, 2010
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemiaSebastian Giebel, Myriam Labopin, Gerhard Ehninger, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2022
Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 yearsSabine Kürzel, André-René Blaudszun, Lilly Stahl, et al.
Pageof 41

Showing results (201-210 of 403) with videos related to

Sort By:
Pageof 41
Haematologica|November 27, 2014
Myelodysplastic syndromes with a deletion 5q display a characteristic immunophenotypic profile suitable for diagnostics and response monitoringUta Oelschlaegel, Theresia M Westers, Brigitte Mohr, et al.
Oncotarget|September 15, 2017
Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpressionTheresa Link, Friederike Kuithan, Armin Ehninger, et al.
Haematologica|June 7, 2007
Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia IntergroupMarkus Schaich, Richard F Schlenk, Haifa K Al-Ali, et al.
Analytical Biochemistry|January 26, 2012
Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapsesSlava Stamova, Anja Feldmann, Marc Cartellieri, et al.
Frontiers in Genetics|January 24, 2022
Sensitive Quantification of Cell-Free Tumor DNA for Early Detection of Recurrence in Colorectal CancerSebastian Stasik, Marika Mende, Caroline Schuster, et al.
Cancer Chemotherapy and Pharmacology|December 6, 2003
Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588Philipp le Coutre, Karl-Anton Kreuzer, Stefan Pursche, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 20, 2017
Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing RegimensAnna Hecht, Seraphina Doll, Heidi Altmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2009
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemiaOlle Ringdén, Myriam Labopin, Gerhard Ehninger, et al.
Blood|April 17, 2010
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemiaSebastian Giebel, Myriam Labopin, Gerhard Ehninger, et al.
Journal of Cancer Research and Clinical Oncology|September 9, 2022
Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 yearsSabine Kürzel, André-René Blaudszun, Lilly Stahl, et al.
Pageof 41